Merck KGaAMerck KGaAMerck KGaA

Merck KGaA

No trades
Last report date
Mar 5, 2026
Report period
Q4 2025
EPS
1.88EUR
Revenue
‪5.25 B‬EUR
Earnings call summary

Solid organic growth in 2025 was achieved despite macro and FX headwinds, with Life Science and Healthcare performing well and Electronics rebounding on AI demand. 2026 guidance anticipates modest sales and EBITDA pre growth, with Process Solutions and Semiconductor Materials as key drivers.

Market capitalization
‪53.50 B‬EUR
6.80EUR
‪2.78 B‬EUR
‪21.16 B‬EUR
‪129.24 M‬
Beta (1Y)
1.08
Employees (FY)
‪62.56 K‬
Change (1Y)
−351 −0.56%
Revenue / Employee (1Y)
‪338.19 K‬EUR
Net income / Employee (1Y)
‪44.39 K‬EUR

About Merck KGaA


CEO
Belén Garijo López
Headquarters
Darmstadt
Founded
1995
IPO date
Oct 20, 1995
Identifiers
2
ISIN DE0006599905
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Check out other big names from the same industry as MRK.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
3.187% YTM
Maturity date Jul 5, 2031
Coupon 0.88% (Fixed)
2.924% YTM
Maturity date Jun 15, 2030
Coupon 2.38% (Fixed)
2.645% YTM
Maturity date Jul 16, 2028
Coupon 0.50% (Fixed)
2.506% YTM
Maturity date Jul 5, 2027
Coupon 0.38% (Fixed)
2.269% YTM
Maturity date Jun 15, 2026
Coupon 1.88% (Fixed)
Maturity date Aug 27, 2054
Coupon 3.88% (Variable)
Maturity date Sep 9, 2080
Coupon 1.63% (Variable)
Maturity date Jun 25, 2079
Coupon 2.88% (Variable)
Maturity date Nov 24, 2055
Coupon 3.75% (Variable)

See all MRK bonds 

Weight 0.05%
Market value ‪282.36 M‬
Weight 0.06%
Market value ‪183.40 M‬
Weight 0.07%
Market value ‪119.59 M‬
Weight 0.87%
Market value ‪84.56 M‬
Weight 0.87%
Market value ‪84.56 M‬
Weight 0.87%
Market value ‪68.81 M‬
Weight 0.87%
Market value ‪68.81 M‬
Weight 0.08%
Market value ‪58.65 M‬
Weight 0.12%
Market value ‪48.29 M‬
Weight 0.15%
Market value ‪45.15 M‬
Weight 0.05%
Market value ‪42.97 M‬

Explore more ETFs 

Frequently Asked Questions


The current price of MRK is 110.15 EUR — it has decreased by −8.00% in the past 24 hours. Watch Merck KGaA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange Merck KGaA stocks are traded under the ticker MRK.
MRK stock has fallen by −10.05% compared to the previous week, the month change is a −9.22% fall, over the last year Merck KGaA has showed a −18.89% decrease.
We've gathered analysts' opinions on Merck KGaA future price: according to them, MRK price has a max estimate of 182.00 EUR and a min estimate of 130.00 EUR. Watch MRK chart and read a more detailed Merck KGaA stock forecast: see what analysts think of Merck KGaA and suggest that you do with its stocks.
MRK reached its all-time high on Dec 30, 2021 with the price of 231.50 EUR, and its all-time low was 8.75 EUR and was reached on Oct 1, 2002. View more price dynamics on MRK chart.
See other stocks reaching their highest and lowest prices.
MRK stock is 4.42% volatile and has beta coefficient of 1.08. Track Merck KGaA stock price on the chart and check out the list of the most volatile stocks — is Merck KGaA there?
Today Merck KGaA has the market capitalization of ‪49.22 B‬, it has decreased by −2.07% over the last week.
Yes, you can track Merck KGaA financials in yearly and quarterly reports right on TradingView.
Merck KGaA is going to release the next earnings report on May 13, 2026. Keep track of upcoming events with our Earnings Calendar.
MRK earnings for the last quarter are 1.88 EUR per share, whereas the estimation was 1.95 EUR resulting in a −3.50% surprise. The estimated earnings for the next quarter are 1.97 EUR per share. See more details about Merck KGaA earnings.
Merck KGaA revenue for the last quarter amounts to ‪5.25 B‬ EUR, despite the estimated figure of ‪5.27 B‬ EUR. In the next quarter, revenue is expected to reach ‪5.08 B‬ EUR.
MRK net income for the last quarter is ‪319.00 M‬ EUR, while the quarter before that showed ‪902.00 M‬ EUR of net income which accounts for 0.00% change. Track more Merck KGaA financial stats to get the full picture.
Yes, MRK dividends are paid annually. The last dividend per share was 2.20 EUR. As of today, Dividend Yield (TTM)% is 1.94%. Tracking Merck KGaA dividends might help you take more informed decisions.
As of Mar 6, 2026, the company has ‪62.56 K‬ employees. See our rating of the largest employees — is Merck KGaA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merck KGaA EBITDA is ‪6.55 B‬ EUR, and current EBITDA margin is 28.17%. See more stats in Merck KGaA financial statements.
Like other stocks, MRK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merck KGaA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Merck KGaA technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Merck KGaA stock shows the sell signal. See more of Merck KGaA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.